Amphastar Pharmaceuticals Quarterly Balance Sheet
NASDAQ: AMPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Amphastar Pharmaceuticals financial position
As of Jun 30, 2026, Amphastar Pharmaceuticals reported total assets of $1.74 billion, up 8.0% from a year earlier against total liabilities of $975.6 million. Shareholders' equity stood at $768.2 million, or 44.1% of assets. The company held $223.6 million in cash and equivalents against $612.1 million of debt, a net debt position of $388.4 million.
The current ratio (current assets divided by current liabilities) was 2.40, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.80.
Summary generated from market data by MetaCap's automated system. Methodology
Amphastar Pharmaceuticals balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 223.61M | 170.94M | 170.18M | 216.26M | 187.69M | 182.78M | 151.61M | 192.12M | 189.62M | 201.15M | 144.30M | 266.78M |
| Short-Term Investments | 66.51M | 121.01M | 112.64M | 59.94M | 44.06M | 54.10M | 70.04M | 58.38M | 28.16M | 88.41M | 112.51M | 33.10M |
| Receivables | 144.86M | 147.85M | 143.56M | 146.81M | 132.98M | 144.64M | 136.29M | 139.63M | 131.41M | 138.11M | 114.94M | 118.99M |
| Inventory | 179.91M | 170.19M | 176.89M | 185.93M | 191.73M | 185.48M | 153.74M | 130.32M | 122.41M | 115.49M | 105.83M | 109.98M |
| Total Current Assets | 630.95M | 633.68M | 636.02M | 639.47M | 580.83M | 587.96M | 534.07M | 545.95M | 482.64M | 555.08M | 489.60M | 543.00M |
| Property, Plant & Equipment | 316.06M | 307.23M | 310.57M | 308.69M | 310.24M | 307.60M | 297.35M | 295.38M | 288.00M | 288.52M | 282.75M | 280.84M |
| Goodwill | 3.31M | 3.33M | 3.40M | 3.40M | 3.40M | 3.16M | 3.05M | 3.26M | 3.13M | 3.15M | 3.22M | 3.09M |
| Intangible Assets | 615.30M | 527.07M | 533.34M | 539.61M | 545.88M | 552.15M | 558.39M | 562.32M | 568.50M | 574.69M | 580.85M | 587.03M |
| Long-Term Investments | — | — | — | — | 2.05M | 5.91M | 11.00M | — | 9.94M | 15.16M | 14.69M | 972.00K |
| Total Assets | 1.74B | 1.65B | 1.63B | 1.67B | 1.62B | 1.63B | 1.58B | 1.55B | 1.49B | 1.57B | 1.51B | 1.54B |
| Accounts Payable | 28.93M | 35.50M | 32.59M | 40.54M | 41.88M | 52.81M | 30.51M | 34.09M | 31.77M | 36.53M | 25.44M | 31.97M |
| Short-Term Debt | 2.49M | 1.67M | 1.64M | 923.00K | 927.00K | 224.00K | 234.00K | 252.00K | 249.00K | 428.00K | 436.00K | 433.00K |
| Total Current Liabilities | 263.20M | 164.48M | 158.16M | 205.23M | 176.41M | 199.05M | 173.76M | 159.01M | 136.97M | 255.17M | 225.41M | 257.96M |
| Long-Term Debt | 609.56M | 609.80M | 619.71M | 608.58M | 607.73M | 603.86M | 613.53M | 596.45M | 586.85M | 594.01M | 603.17M | 653.27M |
| Total Liabilities | 975.61M | 874.77M | 840.49M | 889.48M | 857.85M | 874.99M | 845.17M | 817.50M | 778.18M | 901.96M | 873.49M | 949.49M |
| Shareholders' Equity | 768.16M | 773.39M | 788.80M | 776.75M | 757.48M | 751.28M | 732.30M | 727.68M | 713.35M | 672.36M | 639.42M | 595.14M |
| Retained Earnings | 703.65M | 673.30M | 666.88M | 642.45M | 625.10M | 594.07M | 568.79M | 530.82M | 490.39M | 452.44M | 409.27M | 373.10M |
| Total Debt | 612.05M | 611.47M | 621.35M | 609.50M | 608.65M | 604.08M | 613.77M | 596.70M | 587.10M | 594.43M | 603.61M | 653.70M |
| Net Cash (Debt) | -321.93M | -319.52M | -338.53M | -333.30M | -376.90M | -367.20M | -392.12M | -346.21M | -369.33M | -304.88M | -346.80M | -353.82M |
| Shares Outstanding | 42.53M | 44.64M | 45.65M | 46.35M | 46.49M | 47.67M | 47.62M | 48.37M | 48.96M | 48.84M | 48.07M | 47.90M |
This table shows 12 quarterly periods of Amphastar Pharmaceuticals's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow AMPH's reporting calendar. What is a balance sheet?